An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.
a study on Fibrodysplasia Ossificans Progressiva
Fibrodysplasia Ossificans Progressiva Interventional study Clinical trial phase 3 Efficacy and safety Heterotopic ossification Flare-up Palovarotene Retinoic acid receptor agonist Retinoic acid receptor gamma agonist Clementia Myositis Ossificans Progressiva Munchmeyer's Disease FOP FOP variants Myositis Ossificans
Lead Scientist at UCSF
- Edward Hsiao
Associate Professor, Medicine. Authored (or co-authored) 90 research publications.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Clementia Pharmaceuticals Inc.
- Phase 3
- Study Type
- Last Updated